STELARA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)
Segmentation
By IndicationModerate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy · Psoriatic Arthritis (PsA) · Crohn’s disease (CD) · and Ulcerative Colitis
By Route of AdministrationSubcutaneous Injection · Intravenous Infusion
By Strength45 mg/0.5 mL or 90 mg/mL · 45 mg/0.5 mL
By Dosage Formsingle-dose prefilled syringe · single-dose vial
By End UserHospitals · Specialty Clinics · Infusion centers · and Others